QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.065029v1 310/1/67    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hegde, M. Articles by Gorin, F. Search for Related Content PubMed PubMed Citation Articles by Hegde, M. Articles by Gorin, F.

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Amiloride Kills Malignant Glioma Cells Independent of Its Inhibition of the Sodium-Hydrogen Exchanger

Departments of Neurology (M.H., J.R., F.G.) and Human Physiology (P.C.), School of Medicine, University of California, Davis, Davis, California

Previously, we demonstrated that malignant glioma cell lines have increased intracellular pH (pH_i) as a result of increased activities of the type I sodium/hydrogen exchanger (NHE1). This alkalotic pH_i of 7.2 to 7.4 is favorable for augmented glycolysis, DNA synthesis, and cell cycle progression. Conversely, reductions in pH_i have been associated with reduced rates of proliferation in transformed cell types. The effects of reducing pH_i directly and by NHE1 inhibition on human malignant glioma cells were systematically compared with those on primary rat astrocytes. Neither cariporide, nor direct acidification to pH_i 6.9 altered the proliferative rates or viabilities of human U87 or U118 malignant glioma cell lines. However, amiloride significantly impaired glioma cell proliferation and viability while not affecting astrocytes at concentrations (500 µM) that exceeded its inhibition of NHE1 in glioma cells (IC₅₀ = 17 µM). Preventing a reduction of pH_i did not alter the drug's antiproliferative and cytotoxic effects on glioma cells. These findings indicated that amiloride's cytotoxic effects on glioma cells are independent of its ability to inhibit NHE1 or to reduce intracellular pH_i. The amiloride derivative 2,4 dichlorobenzamil (DCB) inhibits the sodium-calcium exchanger (NCX) and was both antiproliferative and cytotoxic to glioma cells at low doses (20 µM). By contrast, KB-R7943 [(2-[2-[4-nitrobenzyloxy]phenyl]ethyl)-isothioureamethanesulfonate] preferentially blocks sodium-dependent calcium influx by NCX (reverse mode) and was nontoxic to glioma cells. It is proposed that DCB (20 µM) and amiloride (500 µM) impair calcium efflux by NCX, leading to elevations of intracellular calcium that initiate a morphologically necrotic, predominantly caspase-independent glioma cell death.

Address correspondence to: Dr. Fredric Gorin, Department of Neurology, School of Medicine, Center for Neuroscience, 1515 Newton Court, Rm 510, University of California Davis, Davis, CA 95616. E-mail: fagorin{at}ucdavis.edu

This article has been cited by other articles:

				J. H. Overmeyer, A. Kaul, E. E. Johnson, and W. A. Maltese Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis Mol. Cancer Res., June 1, 2008; 6(6): 965 - 977. [Abstract] [Full Text] [PDF]

				H. Palandoken, K. By, M. Hegde, W. R. Harley, F. A. Gorin, and M. H. Nantz Amiloride Peptide Conjugates: Prodrugs for Sodium-Proton Exchange Inhibition J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 961 - 967. [Abstract] [Full Text] [PDF]